SCHEMBL25428652

SCHEMBL25428652

COc1ccc(Cn2cc(-c3[nH]c(=O)c4ccnn4c3Br)cn2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 4/20 0.46
ADORA1 P30542 4/20 0.46
ADORA2A P29274 2/20 0.46
TAS2R8 Q9NYW2 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ERCC5 P28715 1/20 0.39
ADORA3 P0DMS8 2/20 0.37
PDE1B Q01064 3/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
MGAT2 Q10469 1/20 0.36
CREBBP Q92793 2/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
NPBWR1 P48145 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26024152 0.79 GRIN1 (0.45) ADORA2BADORA1ADORA2AL3MBTL1CREBBP
SCHEMBL25431785 0.79 ADORA2A (0.47) ADORA2BADORA1ADORA2ATAS2R8L3MBTL1
SCHEMBL25431462 0.78 ADORA2A (0.40) ADORA2BADORA1ADORA2ATAS2R8L3MBTL1
SCHEMBL21552996 0.72 ADORA2B (0.48) ADORA2BADORA1ADORA2ATAS2R8L3MBTL1
SCHEMBL30719406 0.71 ADORA2A (0.47) ADORA2BADORA1ADORA2AL3MBTL1ERCC5
SCHEMBL25561729 0.69 KMT2A (0.59) L3MBTL1HSP90AA1HSP90AB1NPBWR1MEN1
SCHEMBL3356524 0.69 ADORA2A (0.47) ADORA2BADORA1ADORA2AL3MBTL1HSP90AA1
SCHEMBL17801147 0.68 JAK2 (0.43) ADORA2BADORA1ADORA2AL3MBTL1
SCHEMBL27901467 0.68 L3MBTL1 (0.53) ADORA2BADORA1ADORA2AL3MBTL1HSP90AA1
SCHEMBL17801229 0.67 JAK2 (0.42) ADORA2BADORA1ADORA2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4476204-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS Theras, Inc. (US) 2024-12-18 EP disclosed
CN-118946555-A Compounds having T-structures formed by at least four rings for use in the treatment of cancer and other indications 瑟拉斯有限公司 2024-11-12 CN disclosed
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed